ERBB2 and breast carcinoma: For example, despite the fact that Lapatinib combinationtherapy with Capecitabine has shown success in treatment for HER-2(+ve) advanced breast cancer treatment, asubpopulation of patients often reported occurrences of grade 4 diarrhea, aswell as fatigue, headache, and dizziness [40].